Detalhe da pesquisa
1.
Accuracy of different triage strategies for human papillomavirus positivity in an Italian screening population.
Int J Cancer
; 150(6): 952-960, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34706093
2.
Performance of HPV E6/E7 mRNA assay as primary screening test: Results from the NTCC2 trial.
Int J Cancer
; 151(7): 1047-1058, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35579975
3.
A comparative effectiveness trial of two faecal immunochemical tests for haemoglobin (FIT). Assessment of test performance and adherence in a single round of a population-based screening programme for colorectal cancer.
Gut
; 67(3): 485-496, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27974550
4.
Determinants of Viral Oncogene E6-E7 mRNA Overexpression in a Population-Based Large Sample of Women Infected by High-Risk Human Papillomavirus Types.
J Clin Microbiol
; 55(4): 1056-1065, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28100595
5.
Comparison of HPV-positive triage strategies combining extended genotyping with cytology or p16/ki67 dual staining in the Italian NTCC2 study.
EBioMedicine
; 104: 105149, 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38759278
6.
Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
Acta Cytol
; 56(5): 506-14, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23075891
7.
Determinants of p16/Ki-67 adequacy and positivity in HPV-positive women from a screening population.
Cancer Cytopathol
; 129(5): 383-393, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33142029
8.
p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women.
J Natl Cancer Inst
; 113(3): 292-300, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32745170
9.
Interlaboratory concordance of p16/Ki-67 dual-staining interpretation in HPV-positive women in a screening population.
Cancer Cytopathol
; 128(5): 323-332, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32168431
10.
Evaluation of the FocalPoint GS system performance in an Italian population-based screening of cervical abnormalities.
Acta Cytol
; 51(6): 865-71, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-18077978
11.
Cervical human papilloma virus (HPV) DNA primary screening test: Results of a population-based screening programme in central Italy.
J Med Screen
; 24(3): 153-162, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27614992
12.
Interobserver reproducibility of cytologic p16INK4a /Ki-67 dual immunostaining in human papillomavirus-positive women.
Cancer Cytopathol
; 125(3): 212-220, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27926800
13.
Use of Cytology, E6/E7 mRNA, and p16INK4a-Ki-67 to Define the Management of Human Papillomavirus (HPV)-Positive Women in Cervical Cancer Screening.
Am J Clin Pathol
; 145(1): 35-45, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26712869